TIMOTHY ARCHER - 28 Jun 2024 Form 4 Insider Report for LAM RESEARCH CORP (LRCX)

Signature
Marta Woods by Power of Attorney
Issuer symbol
LRCX
Transactions as of
28 Jun 2024
Net transactions value
-$6,044,106
Form type
4
Filing time
02 Jul 2024, 12:21:49 UTC
Previous filing
14 Mar 2024
Next filing
06 Feb 2025

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LRCX Common Stock Sale $1,500,644 -1,396 -1.4% $1074.96 98,497 28 Jun 2024 Direct F1, F2, F3
transaction LRCX Common Stock Sale $1,668,436 -1,550 -1.6% $1076.41 96,947 28 Jun 2024 Direct F1, F3, F4
transaction LRCX Common Stock Sale $431,356 -400 -0.41% $1078.39 96,547 28 Jun 2024 Direct F1, F3, F5
transaction LRCX Common Stock Sale $432,016 -400 -0.41% $1080.04 96,147 28 Jun 2024 Direct F1, F3, F6
transaction LRCX Common Stock Sale $865,112 -800 -0.83% $1081.39 95,347 28 Jun 2024 Direct F1, F3, F7
transaction LRCX Common Stock Sale $432,980 -400 -0.42% $1082.45 94,947 28 Jun 2024 Direct F1, F3, F8
transaction LRCX Common Stock Sale $542,080 -500 -0.53% $1084.16 94,447 28 Jun 2024 Direct F1, F3, F9
transaction LRCX Common Stock Sale $171,482 -158 -0.17% $1085.33 94,289 28 Jun 2024 Direct F1, F3, F10
holding LRCX Common Stock 4,803 28 Jun 2024 By 401(k)
holding LRCX Common Stock 567 28 Jun 2024 By Spouse 401(k)
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 27, 2024
F2 The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $1,074.77 to $1,075.51 inclusive
F3 The amount reported includes shares subject to unvested restricted stock units.
F4 The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $1,076.00 to $1,076.96 inclusive
F5 The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $1,078.20 to $1,078.57 inclusive
F6 The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $1,079.67 to $1,080.40 inclusive
F7 The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $1,080.96 to $1,081.73 inclusive
F8 The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $1,082.34 to $1,082.55 inclusive
F9 The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $1,083.67 to $1,084.62 inclusive
F10 The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $1,085.33 to $1,085.34 inclusive